ICRS

AM Best Affirms Credit Ratings of MAPFRE S.A.’s Rated Operating Subsidiaries

Thursday, October 14, 2021 - 6:25pm

AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of a+ (Excellent) of MAPFRE S.A.s (MAPFRE) rated operating subsidiaries.

Key Points: 
  • AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of a+ (Excellent) of MAPFRE S.A.s (MAPFRE) rated operating subsidiaries.
  • The ratings reflect MAPFREs balance sheet strength, which AM Best assesses as very strong, as well as its strong operating performance, favourable business profile and appropriate enterprise risk management.
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Bests Credit Ratings .
  • For information on the proper use of Bests Credit Ratings, Bests Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Bests Ratings & Assessments .

AM Best Affirms Credit Ratings of SCOR SE and Its Main Operating Subsidiaries

Wednesday, September 22, 2021 - 3:43pm

AM Best has affirmed the Financial Strength Rating of A+ (Superior) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of aa- (Superior) of SCOR SE (SCOR) (France) and its main operating subsidiaries.

Key Points: 
  • AM Best has affirmed the Financial Strength Rating of A+ (Superior) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of aa- (Superior) of SCOR SE (SCOR) (France) and its main operating subsidiaries.
  • Concurrently, AM Best has affirmed the Long-Term Issue Credit Ratings (Long-Term IR) on SCORs outstanding rated instruments.
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Bests Credit Ratings .
  • For information on the proper use of Bests Credit Ratings, Bests Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Bests Ratings & Assessments .

AM Best Affirms Credit Ratings of Markel Corporation and Its Subsidiaries

Wednesday, September 15, 2021 - 2:46pm

The outlook of these Credit Ratings (ratings) is stable.

Key Points: 
  • The outlook of these Credit Ratings (ratings) is stable.
  • Markel Bermudas ratings also reflect rating enhancement it receives as a result of its strategic importance to the Markel enterprise, as well as the benefits it receives through its relationship with other Markel subsidiaries.
  • Markel is the ultimate parent company of Syndicate 3000s managing agent, Markel Syndicate Management Limited, and of its corporate member, Markel Capital Limited.
  • The ratings of Markel reflect the ratings of its operating insurance subsidiaries, as well as its financial leverage and coverage metrics, which remain within AM Bests guidelines.

Bioventus Proceeds with Option Structure Agreement with CartiHeal

Monday, August 30, 2021 - 12:30pm

DURHAM, N.C., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (Bioventus or the Company), a global leader in innovations for active healing, has elected to make a $50 million escrow payment pursuant to its Option and Equity Purchase Agreement with CartiHeal Ltd., signaling its intent to move forward with an acquisition of CartiHeal.

Key Points: 
  • DURHAM, N.C., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (Bioventus or the Company), a global leader in innovations for active healing, has elected to make a $50 million escrow payment pursuant to its Option and Equity Purchase Agreement with CartiHeal Ltd., signaling its intent to move forward with an acquisition of CartiHeal.
  • The Companys obligation to consummate the Potential Transaction is subject to the exercise by the Company of the call option provided under the Option Agreement, or the exercise by CartiHeal of its put option provided under the Option Agreement.
  • Following the exercise of such option rights, the closing of the Potential Transaction is subject to certain customary conditions to closing.
  • Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

AM Best Affirms Credit Ratings of NCMIC Group’s Members; Revises Issuer Credit Rating Outlook to Negative

Monday, August 16, 2021 - 4:37pm

The Credit Ratings (ratings) reflect NCMICs balance sheet strength, which AM Best assesses as strongest, as well as its strong operating performance, neutral business profile and appropriate enterprise risk management.

Key Points: 
  • The Credit Ratings (ratings) reflect NCMICs balance sheet strength, which AM Best assesses as strongest, as well as its strong operating performance, neutral business profile and appropriate enterprise risk management.
  • The negative Long-Term ICR outlook reflects the decreasing profitability trends in the groups underwriting and operating performance in recent years.
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Bests Credit Ratings .
  • For information on the proper use of Bests Credit Ratings, Bests Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Bests Ratings & Assessments .

Yaron Eshel, Life Science Director for iCAN: Israel-Cannabis to Attend International Cannabinoid Research Society Conference in Leiden, the Netherlands July 1-4

Sunday, July 1, 2018 - 10:01am

TEL AVIV, Israel, July 1, 2018 /PRNewswire/ -- Yaron Eshel, Director of Life Sciences for iCAN: Israel-Cannabis, a globally recognized Israeli company focused on the medical cannabis industry, will attend the International Cannabinoid Research Society conference, to be held in Leiden,the NetherlandsJuly 1st 4th 2018.

Key Points: 
  • TEL AVIV, Israel, July 1, 2018 /PRNewswire/ -- Yaron Eshel, Director of Life Sciences for iCAN: Israel-Cannabis, a globally recognized Israeli company focused on the medical cannabis industry, will attend the International Cannabinoid Research Society conference, to be held in Leiden,the NetherlandsJuly 1st 4th 2018.
  • With experience in development, compliance, and operations, Eshel has worked within Israeli start-ups as well as consulted for them.
  • The International Cannabinoid Research Society, ICRS, is a scientific association with more than 500 international members, all active researchers in the field of endogenous, plant derived and synthetic cannabinoids and related bioactive lipids.
  • iCAN operates across all verticals including: consulting, business development, mentoring, investment strategy, network and media, compliance, and regulation, CRO, commercialization, formulation, and international distribution.

Cannabics Pharmaceuticals to Participate in the International Cannabis Research Society Annual Forum in Leiden, the Netherlands

Tuesday, June 26, 2018 - 6:27pm

The International Cannabinoid Research Society, ICRS, a non-political organization, is dedicated to scientific research in all fields of cannabinoids, ranging from biochemical, chemical and physiological studies of the endogenous cannabinoid system.

Key Points: 
  • The International Cannabinoid Research Society, ICRS, a non-political organization, is dedicated to scientific research in all fields of cannabinoids, ranging from biochemical, chemical and physiological studies of the endogenous cannabinoid system.
  • In attendance will be Dr Haleli Sharir, Dr Nir Kfir, and Dr. Eyal Ballan, the company's Co-Founder and CTO.
  • As a member of a research group, it was observed that human GPR55 can be activated by several types of cannabinoids.
  • Cannabics Pharmaceuticals Inc. (CNBX) is aUnited States-based public company that is developing cannabinoid diagnostic tests for the personalized treatment of cancer.